Inducible Nitric Oxide Synthase Polymorphism And Fatal Cerebral Malaria
- Lancet Ltd
- Publication Type:
- Journal Article
- The Lancet, 1998, 352 (9135), pp. 1193 - 1194
- Issue Date:
Copyright Clearance Process
- Recently Added
- In Progress
- Closed Access
This item is closed access and not available.
There has been much speculation about the part played by nitric oxide (NO) in malaria, both as an antiparasitic agent and as a potential cause of neurosuppression leading to cerebral malaria. and  Investigation is hampered by difficulty in estimating in-vivo production of NO, but genetic studies provide a potential means of examining the relation between NO production and disease outcome. A report from Gabon suggests that a single nucleotide polymorphism in the inducible nitric oxide synthase (NOS2) promoter is associated with protection from all forms of severe malaria, including susceptibility to reinfection.3 We present data from The Gambia suggesting that a similar region of the NOS2 gene encodes a susceptibility determinant for fatal cerebral malaria.
Please use this identifier to cite or link to this item: